Work

Corrigendum to “Pin1 inhibition reverses the acquired resistance of human hepatocellular carcinoma cells to Regorafenib via the Gli1/Snail/E-cadherin pathway” [Cancer Lett. 444 (2019) 82–93]

Year: 2024

Type: erratum

Source: Cancer Letters

DOI: 10.1016/j.canlet.2024.217257

Authors: Jichuang Wang, Nan Zhang, Qi Han, Wenxian Lu, Long Wang, Dayun Yang, Min Zheng, Zhenzhen Zhang, Hekun Liu, Tae Ho Lee, Xiao Zhen Zhou, Kun Ping Lu

Institutions: Fujian Medical University, Broad Institute, Beth Israel Deaconess Medical Center, Harvard University

Language: English

Topic: Signaling Pathways in Disease

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4402935998

Cites:

Cited by:

Related to: 10